Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Anna Beth Bradley, MD
- No relevant financial relationships disclosed.
- Michael J. Brennan, MD
- No relevant financial relationships disclosed.
- Amy Clouse, MD, FAAFP
- Astellas Pharma, Advisor; Astellas Pharma, Speaker
- Anelyssa D'Abreu, MD, MPH, PhD
- No relevant financial relationships disclosed.
- Stephanie Faubion, MD, MBA, FACP, NCMP, IF
- No relevant financial relationships disclosed.
- Katherine E. Galluzzi, DO, CMD, FACOFP
- No relevant financial relationships disclosed.
- Rollin George, MD
- Madrigal Pharmaceuticals, Stock Holder (publicly traded company)
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- OptumRx, Consultant; Premier, Inc., Consultant
- Jonette Keri, MD, PhD
- Almirall, Advisor; L'Oreal, Advisor; Ortho Dermatologics, Advisor; Primus Pharmaceuticals, Advisor
- Mylynda B. Massart, MD, PhD
- GRAIL, LLC, Speaker
- Vani Potluri, MD
- No relevant financial relationships disclosed.
- Kartik Sehgal, MD
- Equinox Group, Inc and Scholar Rock, Inc., Consultant; Exelexis Inc., Advisor; Merck, Researcher
- Tina K. Thethi, MD, MPH
- Bayer and Eli Lilly and Company, Speaker; Bayer and Novo Nordisk, Researcher; Novo Nordisk, Consultant
- Charles Vega, MD, FAAFP
- GlaxoSmithKline, Boehringer Ingelheim, and Exact Sciences, Consultant
Other Disclosures
Pamela Kushner, MD, FAAFP (Moderator, Reviewer): Speaker for Astellas, Bayer, and Corcept; Speaker & Advisor for AstraZeneca, GlaxoSmithKline, Janssen, Novo Nordisk, Lilly/BI, and Phathom; Speaker & Consultant for Haleon; Advisor for Abbott, Bausch/SALIX, Intuity, and Pfizer; Consultant for Abbott, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, and Lilly.
Jennifer Green, MD (Planner): Consultant for Lilly, Novo Nordisk, and AstraZeneca. Consultant and Researcher for Boehringer Ingelheim.
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.